nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—epithelium—Barrett's esophagus	0.0838	0.367	CbGeAlD
Plerixafor—CXCR4—smooth muscle tissue—Barrett's esophagus	0.0807	0.354	CbGeAlD
Plerixafor—CXCR4—digestive system—Barrett's esophagus	0.0637	0.279	CbGeAlD
Plerixafor—Injection site reaction—Omeprazole—Barrett's esophagus	0.0257	0.034	CcSEcCtD
Plerixafor—Injection site reaction—Esomeprazole—Barrett's esophagus	0.0257	0.034	CcSEcCtD
Plerixafor—Swelling—Omeprazole—Barrett's esophagus	0.0213	0.0281	CcSEcCtD
Plerixafor—Swelling—Esomeprazole—Barrett's esophagus	0.0213	0.0281	CcSEcCtD
Plerixafor—Abdominal distension—Omeprazole—Barrett's esophagus	0.0163	0.0216	CcSEcCtD
Plerixafor—Abdominal distension—Esomeprazole—Barrett's esophagus	0.0163	0.0216	CcSEcCtD
Plerixafor—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.0128	0.0169	CcSEcCtD
Plerixafor—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.0128	0.0169	CcSEcCtD
Plerixafor—Immune system disorder—Omeprazole—Barrett's esophagus	0.0117	0.0155	CcSEcCtD
Plerixafor—Immune system disorder—Esomeprazole—Barrett's esophagus	0.0117	0.0155	CcSEcCtD
Plerixafor—Mental disorder—Esomeprazole—Barrett's esophagus	0.0114	0.015	CcSEcCtD
Plerixafor—Mental disorder—Omeprazole—Barrett's esophagus	0.0114	0.015	CcSEcCtD
Plerixafor—Flatulence—Omeprazole—Barrett's esophagus	0.0111	0.0147	CcSEcCtD
Plerixafor—Flatulence—Esomeprazole—Barrett's esophagus	0.0111	0.0147	CcSEcCtD
Plerixafor—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.0105	0.0139	CcSEcCtD
Plerixafor—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.0105	0.0139	CcSEcCtD
Plerixafor—Malaise—Esomeprazole—Barrett's esophagus	0.0102	0.0135	CcSEcCtD
Plerixafor—Malaise—Omeprazole—Barrett's esophagus	0.0102	0.0135	CcSEcCtD
Plerixafor—Arthralgia—Omeprazole—Barrett's esophagus	0.00963	0.0127	CcSEcCtD
Plerixafor—Arthralgia—Esomeprazole—Barrett's esophagus	0.00963	0.0127	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00956	0.0126	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00956	0.0126	CcSEcCtD
Plerixafor—Discomfort—Omeprazole—Barrett's esophagus	0.00951	0.0126	CcSEcCtD
Plerixafor—Discomfort—Esomeprazole—Barrett's esophagus	0.00951	0.0126	CcSEcCtD
Plerixafor—Dry mouth—Esomeprazole—Barrett's esophagus	0.00941	0.0124	CcSEcCtD
Plerixafor—Dry mouth—Omeprazole—Barrett's esophagus	0.00941	0.0124	CcSEcCtD
Plerixafor—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00923	0.0122	CcSEcCtD
Plerixafor—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00923	0.0122	CcSEcCtD
Plerixafor—Shock—Esomeprazole—Barrett's esophagus	0.00908	0.012	CcSEcCtD
Plerixafor—Shock—Omeprazole—Barrett's esophagus	0.00908	0.012	CcSEcCtD
Plerixafor—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00905	0.012	CcSEcCtD
Plerixafor—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00905	0.012	CcSEcCtD
Plerixafor—Skin disorder—Omeprazole—Barrett's esophagus	0.00896	0.0118	CcSEcCtD
Plerixafor—Skin disorder—Esomeprazole—Barrett's esophagus	0.00896	0.0118	CcSEcCtD
Plerixafor—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.00892	0.0118	CcSEcCtD
Plerixafor—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.00892	0.0118	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00841	0.0111	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00841	0.0111	CcSEcCtD
Plerixafor—Insomnia—Esomeprazole—Barrett's esophagus	0.00835	0.011	CcSEcCtD
Plerixafor—Insomnia—Omeprazole—Barrett's esophagus	0.00835	0.011	CcSEcCtD
Plerixafor—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00829	0.0109	CcSEcCtD
Plerixafor—Paraesthesia—Omeprazole—Barrett's esophagus	0.00829	0.0109	CcSEcCtD
Plerixafor—Dyspnoea—Omeprazole—Barrett's esophagus	0.00823	0.0109	CcSEcCtD
Plerixafor—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00823	0.0109	CcSEcCtD
Plerixafor—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00812	0.0107	CcSEcCtD
Plerixafor—Dyspepsia—Omeprazole—Barrett's esophagus	0.00812	0.0107	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00797	0.0105	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00797	0.0105	CcSEcCtD
Plerixafor—Fatigue—Omeprazole—Barrett's esophagus	0.00796	0.0105	CcSEcCtD
Plerixafor—Fatigue—Esomeprazole—Barrett's esophagus	0.00796	0.0105	CcSEcCtD
Plerixafor—Constipation—Esomeprazole—Barrett's esophagus	0.00789	0.0104	CcSEcCtD
Plerixafor—Constipation—Omeprazole—Barrett's esophagus	0.00789	0.0104	CcSEcCtD
Plerixafor—Pain—Esomeprazole—Barrett's esophagus	0.00789	0.0104	CcSEcCtD
Plerixafor—Pain—Omeprazole—Barrett's esophagus	0.00789	0.0104	CcSEcCtD
Plerixafor—Feeling abnormal—Omeprazole—Barrett's esophagus	0.0076	0.01	CcSEcCtD
Plerixafor—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.0076	0.01	CcSEcCtD
Plerixafor—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.00755	0.00997	CcSEcCtD
Plerixafor—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.00755	0.00997	CcSEcCtD
Plerixafor—Urticaria—Esomeprazole—Barrett's esophagus	0.00733	0.00969	CcSEcCtD
Plerixafor—Urticaria—Omeprazole—Barrett's esophagus	0.00733	0.00969	CcSEcCtD
Plerixafor—Abdominal pain—Omeprazole—Barrett's esophagus	0.00729	0.00964	CcSEcCtD
Plerixafor—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00729	0.00964	CcSEcCtD
Plerixafor—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.0068	0.00898	CcSEcCtD
Plerixafor—Hypersensitivity—Omeprazole—Barrett's esophagus	0.0068	0.00898	CcSEcCtD
Plerixafor—Asthenia—Esomeprazole—Barrett's esophagus	0.00662	0.00875	CcSEcCtD
Plerixafor—Asthenia—Omeprazole—Barrett's esophagus	0.00662	0.00875	CcSEcCtD
Plerixafor—Pruritus—Omeprazole—Barrett's esophagus	0.00653	0.00863	CcSEcCtD
Plerixafor—Pruritus—Esomeprazole—Barrett's esophagus	0.00653	0.00863	CcSEcCtD
Plerixafor—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00631	0.00834	CcSEcCtD
Plerixafor—Diarrhoea—Omeprazole—Barrett's esophagus	0.00631	0.00834	CcSEcCtD
Plerixafor—Dizziness—Esomeprazole—Barrett's esophagus	0.0061	0.00806	CcSEcCtD
Plerixafor—Dizziness—Omeprazole—Barrett's esophagus	0.0061	0.00806	CcSEcCtD
Plerixafor—Vomiting—Esomeprazole—Barrett's esophagus	0.00587	0.00775	CcSEcCtD
Plerixafor—Vomiting—Omeprazole—Barrett's esophagus	0.00587	0.00775	CcSEcCtD
Plerixafor—Rash—Omeprazole—Barrett's esophagus	0.00582	0.00769	CcSEcCtD
Plerixafor—Rash—Esomeprazole—Barrett's esophagus	0.00582	0.00769	CcSEcCtD
Plerixafor—Dermatitis—Omeprazole—Barrett's esophagus	0.00581	0.00768	CcSEcCtD
Plerixafor—Dermatitis—Esomeprazole—Barrett's esophagus	0.00581	0.00768	CcSEcCtD
Plerixafor—Headache—Omeprazole—Barrett's esophagus	0.00578	0.00764	CcSEcCtD
Plerixafor—Headache—Esomeprazole—Barrett's esophagus	0.00578	0.00764	CcSEcCtD
Plerixafor—Nausea—Esomeprazole—Barrett's esophagus	0.00548	0.00724	CcSEcCtD
Plerixafor—Nausea—Omeprazole—Barrett's esophagus	0.00548	0.00724	CcSEcCtD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.00392	0.262	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—BMP4—Barrett's esophagus	0.00323	0.216	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CXCL8—Barrett's esophagus	0.00103	0.0685	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.00099	0.0662	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—SST—Barrett's esophagus	0.000835	0.0558	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000664	0.0444	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—SST—Barrett's esophagus	0.000506	0.0338	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GAST—Barrett's esophagus	0.000417	0.0279	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.000386	0.0258	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GAST—Barrett's esophagus	0.000379	0.0253	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.000325	0.0218	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—SST—Barrett's esophagus	0.000286	0.0191	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—SST—Barrett's esophagus	0.00026	0.0174	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000259	0.0173	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SLC9A1—Barrett's esophagus	0.000245	0.0164	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GAST—Barrett's esophagus	0.000224	0.015	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000197	0.0132	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SST—Barrett's esophagus	0.000153	0.0103	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APC—Barrett's esophagus	0.000116	0.00774	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000111	0.00744	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000101	0.00676	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PTGS2—Barrett's esophagus	8.8e-05	0.00588	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APC—Barrett's esophagus	8.11e-05	0.00542	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—RELA—Barrett's esophagus	6.34e-05	0.00424	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CXCL8—Barrett's esophagus	5.97e-05	0.00399	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TP53—Barrett's esophagus	3.67e-05	0.00245	CbGpPWpGaD
